Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue

Stem Cells and Development

Volumn 22, Issue 19, 2013, Pages 2619-2629

  Stubbendorff, Mandy ^a,b   Deuse, Tobias ^a,b,c   Hua, Xiaoqin ^a,b   Phan, Thang T ^d   Bieback, Karen ^e   Atkinson, Kerry ^f,g   Eiermann, Thomas H ^h   Velden, Joachim ⁱ   Schröder, Christine ^h   Reichenspurner, Hermann ^a,b   Robbins, Robert C ^c   Volk, Hans Dieter ^j   Schrepfer, Sonja ^a,b,c  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIOXYGENASE; GAMMA INTERFERON; HLA G ANTIGEN; INDOLAMINE 2,3 DIOXYGENASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EMBRYONIC AND PLACENTAL STRUCTURES; FEMALE; GESTATIONAL TISSUE; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD; UMBILICAL CORD BLOOD; UMBILICAL CORD LINING; WHARTON JELLY;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FETAL BLOOD; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-G ANTIGENS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; PLACENTA; PREGNANCY; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL CORD; UP-REGULATION;

EID: 84884577465     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0043     Document Type: Article

References (42)

1. Caplan AI. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347.
2. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
3. Crop MJ, SS Korevaar, R de Kuiper, JN Ijzermans, NM van Besouw, CC Baan, W Weimar and MJ Hoogduijn. (2011). Human mesenchymal stem cells are susceptible to lysis by CD8+ T-cells and NK cells. Cell Transplant 20:1547-1559.
4. Dahlke MH, M Hoogduijn, E Eggenhofer, FC Popp, P Renner, P Slowik, A Rosenauer, P Piso, EK Geissler, et al. (2009). Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group. Transplantation 88:614-619.
5. Urban VS, J Kiss, J Kovacs, E Gocza, V Vas, E Monostori and F Uher. (2008). Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26: 244-253.
6. Rasmusson I, O Ringden, B Sundberg and K Le Blanc. (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305:33-41.
7. Rasmusson I, O Ringden, B Sundberg and K Le Blanc. (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208-1213.
8. Krampera M, S Glennie, J Dyson, D Scott, R Laylor, E Simpson and F Dazzi. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood 101:3722-3729.
9. Sotiropoulou PA, SA Perez, AD Gritzapis, CN Baxevanis and M Papamichail. (2006). Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74-85.
10. Pradier A, J Passweg, J Villard and V Kindler. (2011). Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity. Cell Transplant 20:681-691.
11. Asari S, S Itakura, K Ferreri, CP Liu, Y Kuroda, F Kandeel and Y Mullen. (2009). Mesenchymal stem cells suppress Bcell terminal differentiation. Exp Hematol 37:604-615.
12. English K, JM Ryan, L Tobin, MJ Murphy, FP Barry and BP Mahon. (2009). Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+ CD25(High) forkhead box P3 + regulatory T cells. Clin Exp Immunol 156:149-160.
13. Wang Q, B Sun, D Wang, Y Ji, Q Kong, G Wang, J Wang, W Zhao, L Jin and H Li. (2008). Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote Tcell tolerance. Scand J Immunol 68:607-615.
14. Potian JA, H Aviv, NM Ponzio, JS Harrison and P Rameshwar. (2003). Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171:3426-3434.
15. Deuse T, M Stubbendorff, K Tang-Quan, N Phillips, MA Kay, T Eiermann, TT Phan, HD Volk, H Reichenspurner, RC Robbins and S Schrepfer. (2011). Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20:655-667.
16. Griffin MD, T Ritter and BP Mahon. (2010). Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 21:1641-1655.
17. Griffin MD, AE Ryan, S Alagesan, P Lohan, O Treacy and T Ritter. (2013). Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: What have we learned so far[quest]. Immunol Cell Biol 91:40-51.
18. Rao MS and MP Mattson. (2001). Stem cells and aging: Expanding the possibilities. Mech Ageing Dev 122:713-734.
19. Ayala-Lugo A, AM Tavares, AH Paz, A Alegretti, L Miquelito, H Bock, R Giugliani, N Clausell, E Cirne-Lima and LE Rohde. (2011). Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction. Cell Transplant 20:407-419.
20. Barlow S, G Brooke, K Chatterjee, G Price, R Pelekanos, T Rossetti, M Doody, D Venter, S Pain, K Gilshenan and K Atkinson. (2008). Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17:1095-1107.
21. Bieback K, S Kern, H Kluter and H Eichler. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634.
22. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. (2004). Mesenchymal stem cells in the Whartońs jelly of the human umbilical cord. Stem Cells 22:1330-1337.
23. Bieback K and I Brinkmann. (2010). Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World J Stem Cells 2:81-92.
24. Kita K, GG Gauglitz, TT Phan, DN Herndon and MG Jeschke. (2010). Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19:491-502.
25. Campeau E, VE Ruhl, F Rodier, CL Smith, BL Rahmberg, JO Fuss, J Campisi, P Yaswen, PK Cooper and PD Kaufman. (2009). A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4:e6529.
26. Gang EJ, D Bosnakovski, CA Figueiredo, JW Visser and RC Perlingeiro. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751.
27. Kern S, H Eichler, J Stoeve, H Kluter and K Bieback. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301.
28. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
29. Khalil-Daher I, B Riteau, C Menier, C Sedlik, P Paul, J Dausset, ED Carosella and N Rouas-Freiss. (1999). Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 43:175-182.
30. Selmani Z, A Naji, E Gaiffe, L Obert, P Tiberghien, N Rouas-Freiss, ED Carosella and F Deschaseaux. (2009). HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 87:S62-S66.
31. Meisel R, A Zibert, M Laryea, U Gobel, W Daubener and D Dilloo. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation. Blood 103:4619-4621.
32. Munn DH, M Zhou, JT Attwood, I Bondarev, SJ Conway, B Marshall, C Brown and AL Mellor. (1998). Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193.
33. Beltrami AP, D Cesselli, N Bergamin, P Marcon, S Rigo, E Puppato, F D'Aurizio, R Verardo, S Piazza, et al. (2007). Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110:3438-3446.
34. Hegyi B, B Sagi, J Kovacs, J Kiss, VS Urban, G Meszaros, E Monostori and F Uher. (2010). Identical, similar or different?. Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: Bone marrow, spleen, thymus and aorta wall. Int Immunol 22:551-559.
35. Bieback K, S Kern, A Kocaomer, K Ferlik and P Bugert. (2008). Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 18:S71-S76.
36. da Silva Meirelles L, AI Caplan and NB Nardi. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287-2299.
37. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
38. Nauta AJ, G Westerhuis, AB Kruisselbrink, EG Lurvink, R Willemze and WE Fibbe. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108:2114-2120.
39. Navarro F, M Llano, T Bellon, M Colonna, DE Geraghty and M Lopez-Botet. (1999). The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLAE molecules co-expressed on target cells. Eur J Immunol 29:277-283.
40. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
41. Gotherstrom C, O Ringden, M Westgren, C Tammik and K Le Blanc. (2003). Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32:265-272.
42. Roelen DL, BJ van der Mast, PS ińt Anker, C Kleijburg, M Eikmans, E van Beelen, GM de Groot-Swings, WE Fibbe, HH Kanhai, SA Scherjon and FH Claas. (2009). Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells. Hum Immunol 70:16-23.